The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma
Min Pan(St. Jude Children's Research Hospital), Paul Geeleher(St. Jude Children's Research Hospital)
Cited by 90
Related Papers
An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programs
|bioRxiv (Cold Spring Harbor Laboratory)|2023|3
An open-source screening platform accelerates discovery of drug combinations
|Nature Communications|2025|3
Abstract 1907: Combocat: A high-throughput framework for drug combination studies
|Cancer Research|2022|0
Prodrug florfenicol amine is activated by intrinsic resistance to target Mycobacterium abscessus
|Nature Microbiology|2025|0